Weekly Reports | Nov 22 2019
Our top ten news from 14 November 2019 to 21 November 2019 (ranked according to popularity).
Dear time-poor reader:Â Preview to S&P December index re-weighting and long term trends reflected in index changes
In this week’s Weekly Insights (this is Part Two):
-Positive Momentum Continues For CSL
-Conviction Calls
-Focus On Index Changes
The sudden burst of buying interest appearing two weeks ago in the uranium market continued last week as producers stepped in.
Dear time-poor reader: why CSL continues enjoying upward momentum plus further updates on broker Conviction Calls
In this week’s Weekly Insights (published in two parts):
-Positive Momentum Continues For CSL
-Conviction Calls
-Focu
National Australia Bank has prevailing themes in common with its major peers yet brokers diverge in their views on the outlook for the stock.
Appen has upgraded guidance for 2019, underpinned by its core Relevance revenue and largely from existing customers. Figure Eight provides the extra potential in 2020.
A glance through the latest expert views and predictions about commodities. Guinea; iron ore; base metals; and coal in China.
Weekly Broker Wrap: cash rate; economic outlook; house prices; car sales; platforms; retail online; waste management; and drought.
Thursday 14 November 2019 – 01:15 PM
Medical technology group HeraMED Limited has gone from strength to strength since listing on the ASX in December 2018.
The New Criterion’s Tim Boreham tracks the performance of Australian stocks most recently targeted by short-sellers.
Coca-Cola Amatil expects a return to growth in 2020 with both channel and product mix providing positive impetus to revenue.
